Literature DB >> 8412005

Osteoporosis in lysinuric protein intolerance.

K Parto1, R Penttinen, I Paronen, L Pelliniemi, O Simell.   

Abstract

Lysinuric protein intolerance (LPI) is an autosomal recessive disease characterized by defective transport of cationic amino acids. Patients have an increased incidence of fractures and their skeletal radiographs show osteoporosis. The aim of the study was to characterize the osteopenia in LPI. Twenty-nine Finnish LPI patients (age range 3.7-44.4 years) were screened for parameters of bone metabolism. Morphometric analysis of bone was carried out in specimens of 9 patients. Collagen synthesis was studied with cultured skin fibroblasts (4 patients) and collagen fibril sizes (3 patients) were measured using electron microscopy. Most histological bone specimens (8/9) showed osteoporosis. Osteomalacia was excluded. Routine clinical laboratory tests were unrevealing. The concentrations of free hydroxyproline and type III procollagen N-propeptide in serum and the urinary excretion of hydroxyproline were increased in almost all patients during their growth and in about half of adult patients. Collagen synthesis in LPI fibroblast cultures was significantly decreased compared with that in age-matched controls at 5 (p < 0.01), 14 (p < 0.01) and still at 30 years (p < 0.01), whereas no difference was observed at the age of 44 years (p = N.S.). Osteoporosis in LPI might reflect defective matrix protein synthesis caused by protein deprivation and deficiency of cationic amino acids. Increased collagen turnover can also contribute to the osteoporosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8412005     DOI: 10.1007/bf00710296

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  32 in total

1.  Growth velocity, growth hormone therapy, and serum concentrations of the amino-terminal propeptide of type III procollagen.

Authors:  P Trivedi; P Hindmarsh; J Risteli; L Risteli; A P Mowat; C G Brook
Journal:  J Pediatr       Date:  1989-02       Impact factor: 4.406

Review 2.  Bone mineral and matrix. Are they altered in osteoporosis?

Authors:  A L Boskey
Journal:  Orthop Clin North Am       Date:  1990-01       Impact factor: 2.472

3.  In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain.

Authors:  T R Chen
Journal:  Exp Cell Res       Date:  1977-02       Impact factor: 3.905

4.  Lysinuric protein intolerance.

Authors:  O Simell; J Perheentupa; J Rapola; J K Visakorpi; L E Eskelin
Journal:  Am J Med       Date:  1975-08       Impact factor: 4.965

5.  Oral administration of arginine and citrulline in the treatment of lysinuric protein intolerance.

Authors:  N Mizutani; T Kato; M Maehara; K Watanabe; M Ban
Journal:  Tohoku J Exp Med       Date:  1984-01       Impact factor: 1.848

6.  Metabolism of collagen in aspartylglycosaminuria: decreased synthesis by cultured fibroblasts.

Authors:  K Näntö-Salonen; R Penttinen
Journal:  J Inherit Metab Dis       Date:  1982       Impact factor: 4.982

7.  Skeletal manifestations of lysinuric protein intolerance. A follow-up study of 29 patients.

Authors:  E Svedström; K Parto; M Marttinen; P Virtama; O Simell
Journal:  Skeletal Radiol       Date:  1993       Impact factor: 2.199

8.  Feedback regulation of collagen gene expression: a Trojan horse approach.

Authors:  L Fouser; E H Sage; J Clark; P Bornstein
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

9.  Lysinuric protein intolerance. Basolateral transport defect in renal tubuli.

Authors:  J Rajantie; O Simell; J Perheentupa
Journal:  J Clin Invest       Date:  1981-04       Impact factor: 14.808

10.  Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen.

Authors:  J Melkko; S Niemi; L Risteli; J Risteli
Journal:  Clin Chem       Date:  1990-07       Impact factor: 8.327

View more
  11 in total

1.  Nutrient intake in lysinuric protein intolerance.

Authors:  L M Tanner; K Näntö-Salonen; J Venetoklis; S Kotilainen; H Niinikoski; K Huoponen; O Simell
Journal:  J Inherit Metab Dis       Date:  2007-06-21       Impact factor: 4.982

2.  Immune complex disease consistent with systemic lupus erythematosus in a patient with lysinuric protein intolerance.

Authors:  H Parsons; F Snyder; T Bowen; J Klassen; A Pinto
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

3.  Does dietary protein reduce hip fracture risk in elders? The Framingham Osteoporosis Study.

Authors:  D Misra; S D Berry; K E Broe; R R McLean; L A Cupples; K L Tucker; D P Kiel; M T Hannan
Journal:  Osteoporos Int       Date:  2010-05-05       Impact factor: 4.507

4.  A global Slc7a7 knockout mouse model demonstrates characteristic phenotypes of human lysinuric protein intolerance.

Authors:  Bridget M Stroup; Ronit Marom; Xiaohui Li; Chih-Wei Hsu; Cheng-Yen Chang; Luan D Truong; Brian Dawson; Ingo Grafe; Yuqing Chen; Ming-Ming Jiang; Denise Lanza; Jennie Rose Green; Qin Sun; J P Barrish; Safa Ani; Audrey E Christiansen; John R Seavitt; Mary E Dickinson; Farrah Kheradmand; Jason D Heaney; Brendan Lee; Lindsay C Burrage
Journal:  Hum Mol Genet       Date:  2020-08-03       Impact factor: 6.150

5.  Lung involvement in children with lysinuric protein intolerance.

Authors:  Sarah Valimahamed-Mitha; Laureline Berteloot; Héloise Ducoin; Chris Ottolenghi; Pascale de Lonlay; Jacques de Blic
Journal:  J Inherit Metab Dis       Date:  2014-10-22       Impact factor: 4.982

Review 6.  Inborn errors of metabolism underlying primary immunodeficiencies.

Authors:  Nima Parvaneh; Pierre Quartier; Parastoo Rostami; Jean-Laurent Casanova; Pascale de Lonlay
Journal:  J Clin Immunol       Date:  2014-08-01       Impact factor: 8.317

7.  Legumes and meat analogues consumption are associated with hip fracture risk independently of meat intake among Caucasian men and women: the Adventist Health Study-2.

Authors:  Vichuda Lousuebsakul-Matthews; Donna L Thorpe; Raymond Knutsen; W Larry Beeson; Gary E Fraser; Synnove F Knutsen
Journal:  Public Health Nutr       Date:  2013-10-08       Impact factor: 4.022

8.  Lysinuric Protein Intolerance Presenting with Multiple Fractures.

Authors:  Jennifer E Posey; Lindsay C Burrage; Marcus J Miller; Pengfei Liu; Matthew T Hardison; Sarah H Elsea; Qin Sun; Yaping Yang; Alecia S Willis; Alan E Schlesinger; Carlos A Bacino; Brendan H Lee
Journal:  Mol Genet Metab Rep       Date:  2014

9.  Update on Lysinuric Protein Intolerance, a Multi-faceted Disease Retrospective cohort analysis from birth to adulthood.

Authors:  Wladimir Mauhin; Florence Habarou; Stéphanie Gobin; Aude Servais; Anaïs Brassier; Coraline Grisel; Célina Roda; Graziella Pinto; Despina Moshous; Fahd Ghalim; Pauline Krug; Nelly Deltour; Clément Pontoizeau; Sandrine Dubois; Murielle Assoun; Louise Galmiche; Jean-Paul Bonnefont; Chris Ottolenghi; Jacques de Blic; Jean-Baptiste Arnoux; Pascale de Lonlay
Journal:  Orphanet J Rare Dis       Date:  2017-01-05       Impact factor: 4.123

10.  Immune Dysregulation Mimicking Systemic Lupus Erythematosus in a Patient With Lysinuric Protein Intolerance: Case Report and Review of the Literature.

Authors:  Josefina Longeri Contreras; Mabel A Ladino; Katherine Aránguiz; Gonzalo P Mendez; Zeynep Coban-Akdemir; Bo Yuan; Richard A Gibbs; Lindsay C Burrage; James R Lupski; Ivan K Chinn; Tiphanie P Vogel; Jordan S Orange; M Cecilia Poli
Journal:  Front Pediatr       Date:  2021-05-20       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.